Optimal strategies for regional cultivar testing

In undertaking cultivar trials, the variability of the response of the cultivars to the different environments in which they are grown introduces the possibility of release errors and non‐release errors in the decisions made on the basis of the trial results. In this article a model is developed that accounts for the economic costs of those errors as well as the costs of operating the trials, and enables the features of the optimal cultivar testing program to be identified. The model is illustrated by application to wheat cultivar trials in central and southern NSW.Crop Production/Industries,

Salinity investment framework : agricultural land and infrastructure

Greater awareness of the potential impact of salinity has led to increased public and private expenditure. The Salinity Investment Framework was developed to insert rigour and accountability into decision-making processes and guide future development. This report focusses on the economic impact of salinity on private and public land and the infrastructure of areas in Western Australia, including towns, railway systems, roads and the like

Book reviews

Teaching/Communication/Extension/Profession,

The acute effect of ‘breaking-up’ prolonged sitting on cardiovascular risk factors in overweight/obese adults

Session - Physical activity and cardiovascular disease in adults: paper no. 562This journal suppl. entitled: Be Avtive 2012INTRODUCTION: We have recently shown in a controlled laboratory setting that regularly ‘breaking up’ prolonged sitting with frequent short bouts of light-or moderate-intensity walking activity acutely lowers postprandial blood glucose and insulin concentrations. However, we are yet to report the effect of interrupting sitting time on secondary outcomes relating to cardiovascular disease. Consequently, we compared the effect of a single prolonged (7-hour) bout of sitting with a similar duration of sitting combined with intermittent bouts of light-intensity or moderate-intensity activity on blood pressure, blood lipids and CRP. METHODS: Overweight/obese adults (n=19; age range 45–65 yrs) were recruited for a randomized three-week, three-treatment acute cross-over trial: 1) uninterrupted sitting; 2) seated with 2-minute bouts of light-intensity walking at 3.2 km/hr every 20 minutes; and 3) seated with 2-minute bouts of moderate-intensity walking at between 5.8–6.4 km/hr every 20 minutes. Following the completion of baseline measurements and an initial 2 hour steady-state period, participants consumed a standard test meal (75 g glucose, 50 g fat). Serum triglycerides were assessed hourly to calculate the incremental area under the curve (iAUC) and high sensitivity C-reactive protein (hsCRP) was assessed at baseline and 7 hours. Seated brachial artery blood pressure was also measured every hour as a single measurement, 5 mins prior to each activity bout, with an automated oscillometric blood pressure monitor (Philips SureSigns VS3 Monitor). GEE models were adjusted for sex, age, BMI, fasting blood pressure and treatment order. RESULTS: Systolic blood pressure decreased similarly and significantly during the light and moderate-intensity activity conditions [light: 120±4mmHg (hourly mean±SEM), p=0.002; moderate: 120±3mmHg, p=0.02] compared to uninterrupted sitting (125±4mmHg). Diastolic blood pressure was also significantly reduced with both activity conditions (light: 78±3mmHg, p=0.006; moderate: 78±3mmHg, p=0.03) compared to uninterrupted sitting (79±3mmHg). No significant group differences were observed in triglyceride iAUC, hsCRP and the hourly measurement of heart rate. DISCUSSION: These findings indicate that breaking up prolonged sitting with frequent short breaks of either light or moderate-intensity physical activity may have favourable effects on seated blood pressure. Further studies are needed to evaluate the chronic effects of breaking up sedentary time on cardiovascular disease risk factors and the feasibility of such strategies in the general community

Sheep Updates 2005 - Part 1

This session covers seven papers from different authors: Boosting lambing percentages of WA sheep flocks. R.W. Kelly CSIRO Livestock Industries, Floreat WA , R. Kingwell Department of Agriculture WA, Kiwis can fly - 30% higher lambing in 15 years, AR Bray, Meat and Wool New Zealand, Wellington, New Zealand Rams are not a trivial expense, so what can you do to maximise on your investment? Chri Oldham, Department of Agriculture Western Australia, Graeme Martin, University of West Australia. Care for mun - fetal programming, lamb survival and lifetime performance. RW Kelly CSIRO Livestock Industries, Floreat WA Boost lamb survival - select calm ewes, D Blanch University of western Australia, D Ferguson CSIRO FD McMaster Lab, NSW Getting high marking percentages in WA, Keith Crocker, Department of Agriculture Western Australia. Healthy, Welfare and Wise! Di Evans, Department of Agriculture Western Australi

Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study

OBJECTIVE: To determine whether better medication adherence in multiple sclerosis (MS) might be due to specialised disease-modifying drug (DMD) support programmes by: (1) establishing higher adherence in MS than in other chronic diseases and (2) determining if higher adherence is associated with patient-specific or treatment-specific factors. DESIGN: Retrospective cohort study with data from 1 January 1996 to 31 December 2015. SETTING: Population-based health administrative data from three Canadian provinces. PARTICIPANTS: Individual cohorts were created using validated case definitions for MS, epilepsy, Parkinson's disease (PD) and rheumatoid arthritis (RA). Subjects were included if they received ≥1 dispensation for a disease-related drug between 1 January 1997 and 31 December 2014. MAIN OUTCOME MEASURES: Proportion of subjects with optimal adherence (≥80%) measured by the medication possession ratio 1 year after the index date (first dispensation of disease-related drug). RESULTS: 126 478 subjects were included in the primary analysis (MS, n=6271; epilepsy, n=55 739; PD, n=21 304; RA, n=43 164). Subjects with epilepsy (adjusted OR, aOR 0.29; 95% CI 0.19 to 0.45), PD (aOR 0.42; 95% CI 0.29 to 0.63) or RA (aOR 0.26; 95% CI 0.19 to 0.35) were less likely to have optimal 1-year adherence compared with subjects with MS. Within the MS cohort, adherence was higher for DMD than for chronic-use non-MS medications, and no consistent patient-related predictors of adherence were observed across all four non-MS medication classes, including having optimal adherence to DMD. CONCLUSIONS: Subjects with MS were significantly more likely to have optimal 1-year adherence than subjects with epilepsy, RA and PD, and optimal adherence appears related to treatment-specific factors rather than patient-related factors. This supports the hypothesis that higher adherence to the MS DMDs could be due to the specialised support programmes; these programmes may serve as a model for use in other chronic conditions

Hormone Therapy Reduces Bone Resorption but not Bone Formation in Postmenopausal Athletes

INTRODUCTION: Independently, hormone therapy and exercise have well-established protective effects on bone parameters. The combined effects of hormone therapy and exercise, however, are less clear. We, therefore, examined the effects of hormone therapy on bone turnover markers in postmenopausal women undergoing regular high intensity exercise. METHODS: In a randomised, double blind study, postmenopausal athletes competing at Masters level, received either hormone therapy (50 μg transdermal oestradiol, 5 mg MPA, n = 8) or placebo (n = 7) for 20 weeks. Women were tested before and after treatment for plasma concentrations of oestradiol, FSH, LH, and serum bone formation marker -osteocalcin (OC); and urine bone resorption markers-pyridinoline (PYD) and deoxypyridinoline (DPD). RESULTS: As a result of treatment with hormone therapy there were significant reductions in levels of FSH (73.3 ± 13.7 to 48.6 ± 10.5 mmol/L, p = 0.01) and bone resorption markers (PYD, 81.9 ± 7.7 to 57.8 ± 3.7 nmol/mmol Cr, p = 0.001, and DPD, 18.5 ± 3.1 to 11.8 ± 2.1 nmol/mmol Cr, p = 0.01). Oestradiol and bone formation markers were not significantly altered as a result of hormone therapy. There were no changes to any variables with placebo treatment. CONCLUSION: Hormone therapy reduced bone resorption, but not bone formation, in postmenopausal athletes. These favorable reductions in bone turnover; therefore, provide an effective treatment in combination with high intensity exercise to further reduce the subsequent risk of osteoporosis and associated fractures

Archaeobotanical Investigations into Golbai Sasan and Gopalpur, Two Neolithic-Chalcolithic Settlements of Odisha

This paper presents the results of plant macro-remain and phytolith analyses from two Neolithic-Early Historic mounded settlement sites in Odisha, eastern India: Gopalpur and Golbai Sasan. Macrobotanical and phytolith samples were taken throughout the stratigraphy and the results are presented here. The plant remains confirm the presence of a distinct agricultural economy in Neolithic-Chalcolithic Odisha based on rice (Oryza sativa), pulses (Vigna spp., Macrotyloma uniflorium and Cajanus cajan) and millets (Bracharia ramosa, Panicum spp., Setaria spp. and possibly Paspalum sp.). Crop processing activities have been reconstructed using both phytoliths and macro-remains, and suggest that threshing occurred off site as part of a communal harvesting strategy. Potential differences between the economies of Golbai Sasan and Gopalpur are suggested, with a broader range of pulses present at Gopalpur. Radiocarbon dates from individual rice grains and legumes provide a secure chronology for the sites. This paper therefore provides the first published details for the agricultural base of the Neolithic-Chalcolithic coastal lowlands in Odisha, as well as new AMS radiocarbon dates for the Odishan Neolithic-Chalcolithic period